Metastatic cutaneous squamous cell carcinoma

Overview of Metastatic Cutaneous Squamous Cell Carcinoma

Metastatic cutaneous squamous cell carcinoma (mSCC) is a type of skin cancer. This aggressive cancer begins in the cells of the epidermis, or outer layer of skin, and can spread to other organs in the body.

When mSCC spreads from its original site, it is called metastatic, and it can spread to the lymph nodes, lungs, bones, and other organs. If not treated promptly, mSCC can be fatal.

The primary signs and symptoms of mSCC include areas of red, scaly skin, crusting of the skin, and persistent sores. The areas may become painful and infected, and the lesions may spread to other parts of the body. As mSCC progresses, it can cause severe pain and other complications.

Diagnosis and Treatment of Metastatic Cutaneous Squamous Cell Carcinoma

The diagnosis of mSCC is made through a biopsy of the affected area. The sample of skin is examined for signs of metastatic disease, and additional tests may be used to look for signs of tumor or other diseases. Once a diagnosis is made, treatment usually includes surgery, radiation therapy, or chemotherapy.

Surgery is the most common treatment for mSCC. The tumor and any surrounding tissue are removed surgically. In some cases, surgery may be combined with radiation therapy or chemotherapy to reduce the size of the tumor before it is removed.

Radiation therapy is often used in combination with chemotherapy or surgery to shrink the tumor. The radiation destroys cancer cells and may be combined with chemotherapy to provide greater effectiveness in treating mSCC.

Chemotherapy drugs are used to kill cancer cells that are not destroyed by other treatments. These drugs can cause side effects, such as hair loss, nausea, and loss of appetite.

Prevention and Prognosis of Metastatic Cutaneous Squamous Cell Carcinoma

The best way to reduce the risk of getting mSCC is to avoid overexposure to the sun and to use protective clothing, hats, and sunscreen. It is also important to inspect the skin regularly for signs of mSCC, such as red, scaly areas, and to schedule regular visits with a dermatologist.

The prognosis of mSCC depends on the stage of the cancer and how effectively it is treated. The earlier the cancer is detected and treated, the better the outcome is likely to be.